Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality

Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality

Non-vitamin K antagonist oral anticoagulants (NOACs) represent a paradigm shift in the treatment of non-valvular atrial fibrillation (AF) with major practice guidelines around the world recommending NOACs over vitamin K antagonist oral anticoagulants for initial treatment of AF for stroke prevention...

Full description

Bibliographic Details
Main Authors:	Ezequiel J. Zaidel, Xinyi Leng, Abiodun Moshood Adeoye, Ferdous Hakim, Biraj Karmacharya, Asim Katbeh, Lis Neubeck, Stephanie Partridge, Pablo Perel, Mark D. Huffman, Mariachiara Di Cesare
Format:	Article
Language:	English
Published:	Ubiquity Press 2020-08-01
Series:	Global Heart
Subjects:	non-valvular atrial fibrillation non-vitamin k antagonist oral anticoagulants (noacs) essential medicine list stroke prevention
Online Access:	https://globalheartjournal.com/articles/608

Similar Items

Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
by: Patita Sitticharoenchai, et al.
Published: (2021-04-01)

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
by: Qiyu He, et al.
Published: (2019-05-01)

Direct Acting Oral Anticoagulant vs. Warfarin in the Prevention of Thromboembolism in Patients With Non-valvular Atrial Fibrillation With Valvular Heart Disease—A Systematic Review and Meta-Analysis
by: Januar Wibawa Martha, et al.
Published: (2021-12-01)

Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01)

Pregnancy and non-valvular heart disease - Anesthetic considerations
by: Maitra Gaurab, et al.
Published: (2010-01-01)

Anticoagulation in Patients with End-Stage Renal Disease and Non-Valvular Atrial Fibrillation – Review Article
by: Mahmoud Khalifa, et al.
Published: (2021-05-01)

Is There Association Between Changes in eGFR Value and the Risk of Permanent Type of Atrial Fibrillation? - Analysis of Valvular and Non-Valvular Atrial Fibrillation Population
by: Elzbieta Mlodawska, et al.
Published: (2014-12-01)

Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry
by: Sergio Dubner, et al.
Published: (2020-12-01)

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
by: Faye L. Norby, et al.
Published: (2017-09-01)

Two Approaches to Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Treated with Percutaneous Coronary Intervention: Which Is More Efficient and Safer?
by: Witold Bachorski, et al.
Published: (2023-09-01)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
by: Ya-ou Liu, et al.
Published: (2022-10-01)

Gender-related differences in presentation and treatment of patients with non-valvular atrial fibrillation: results from RAMSES study
by: Volkan Doğan, et al.
Published: (2017-01-01)

STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION. WHAT ROCKET AF STUDY RESULTS SAY
by: I. S. Yavelov
Published: (2017-11-01)

Progress in the Application of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation and Chronic Renal Insufficiency
by: LI Xin, et al.
Published: (2022-03-01)

Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
by: Daiki Shimomura, et al.
Published: (2015-08-01)

Association between g-glutamyl transferase level and the onset of non-valvular atrial fibrillation in Chinese population
by: Lihua Pan, et al.
Published: (2022-05-01)

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
by: Marco Bellone, et al.
Published: (2018-02-01)

Evaluación del tratamiento de la fibrilación auricular valvular y no valvular y su relación con eventos adversos en pacientes hospitalizados en el servicio de urgencias de un hospital de tercer nivel
by: Angélica María Rojas-Durán, et al.
Published: (2020-11-01)

Recambio valvular aórtico
by: Cipriano Abad
Published: (2016-12-01)

Do Apixaban Plasma Levels Relate to Bleeding? The Clinical Outcomes and Predictive Factors for Bleeding in Patients with Non-Valvular Atrial Fibrillation
by: Sutee Limcharoen, et al.
Published: (2022-08-01)

Total Bilirubin Level is Associated with the Risk of Left Atrial Appendage Thrombosis in Patients with Non-Valvular Atrial Fibrillation
by: Weihao Meng, et al.
Published: (2022-12-01)

Association between lipoprotein(a) and thromboembolism in patients with non-valvular atrial fibrillation: a cross-sectional study
by: Jie Song, et al.
Published: (2022-08-01)

Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants
by: U Fan O, et al.
Published: (2022-06-01)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
by: Jia Wu, et al.
Published: (2020-07-01)

Assessing physicians’ knowledge, attitude, and practice on anticoagulant therapy in non-valvular atrial fibrillation: Syrian insights
by: Sarya Swed, et al.
Published: (2024-03-01)

Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
by: Hua Wang, et al.
Published: (2022-11-01)

Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration
by: Shujuan Zhao, et al.
Published: (2020-08-01)

Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China
by: Zhongping An, et al.
Published: (2017-04-01)

Doble reemplazo valvular transaórtico
by: Alejandro Martín-Trenor, et al.
Published: (2014-10-01)

Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015)
by: M. Sabaté, et al.
Published: (2021-11-01)

Estenosis Valvular Aortica.
by: Genoveva Elva Henry, et al.
Published: (2018-02-01)

The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation
by: Tingting Wu, et al.
Published: (2023-07-01)

Increased levels of red cell distribution width is correlated with presence of left atrial stasis in patients with non-valvular atrial fibrillation
by: Adnan Kaya, et al.
Published: (2017-05-01)

Association between red blood cell distribution width and non-valvular atrial fibrillation in hemodialysis patients: a single-center Chinese population study
by: Tao Zhang, et al.
Published: (2022-12-01)

Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation
by: Steven Deitelzweig, et al.
Published: (2024-02-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Effect of Evidence-Based Pharmacy Care on Satisfaction and Cognition in Patients with Non-Valvular Atrial Fibrillation Taking Rivaroxaban
by: Sun J, et al.
Published: (2021-07-01)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01)

Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study
by: Huang H, et al.
Published: (2023-08-01)

Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences
by: Yoga Waranugraha, et al.
Published: (2021-08-01)